1800-272-662
Shopping Cart 0
countryflagAU
Login

EVE Health Group Limited

Consumer Defensive AU EVE

0.021AUD
-(-%)

Last update at 2026-03-13T04:31:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.04
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap5.98M
  • Volume355946
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.65271M
  • Revenue TTM1.36M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 0.66M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -1.45296M -1.54900M -2.34949M -5.37195M -3.63069M
Minority interest - - - - -
Net income -1.57995M -1.90100M -3.07032M -5.37195M -3.63069M
Selling general administrative 0.95M 0.99M 1.33M 2.24M 2.50M
Selling and marketing expenses 0.95M 1.13M 1.26M 2.01M 1.25M
Gross profit 0.82M 0.88M 0.83M 0.98M 1.64M
Reconciled depreciation 0.00018M 0.00704M 0.17M 0.33M 0.32M
Ebit -1.42586M -1.51404M -2.26042M -4.54309M -3.58234M
Ebitda -1.42568M -1.50700M -2.09352M -4.21735M -3.25783M
Depreciation and amortization 0.00018M 0.00704M 0.17M 0.33M 0.32M
Non operating income net other - - - - -
Operating income -1.42828M -1.54400M -2.33986M -4.21945M -3.79144M
Other operating expenses 3.16M 3.68M 1.67M 4.58M 3.39M
Interest expense 0.03M 0.03M - 0.00720M 0.05M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00128M 0.03M 0.02M 0.00720M 0.03M
Net interest income -0.02710M -0.03492M 0.00012M -4.00210M -0.02201M
Extraordinary items -0.12700M -0.35229M 0.72M 0.25M -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.35M 0.81M -0.21629M -0.05346M
Total revenue 1.73M 2.13M 2.33M 2.39M 2.80M
Total operating expenses 2.25M 2.42M 3.18M 5.31M 5.14M
Cost of revenue 0.91M 1.26M 1.50M 1.41M 1.16M
Total other income expense net -0.02467M -0.00517M 0.00066M -1.04515M -0.10181M
Discontinued operations - - -1.69440M -0.25355M -0.25355M
Net income from continuing ops -1.45296M -1.54870M -2.34949M -5.37195M -3.63069M
Net income applicable to common shares -1.57996M -1.90099M -1.62867M -5.37195M -3.63069M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 4.12M 2.52M 5.11M 8.07M 11.92M
Intangible assets 3.00M - 0.00000M 0.10M 0.11M
Earning assets - - - - -
Other current assets - 2.20M 4.18M 0.08M 0.09M
Total liab 0.57M 1.30M 1.01M 1.14M 1.74M
Total stockholder equity 3.55M 1.22M 4.10M 6.93M 10.19M
Deferred long term liab - - - - -
Other current liab - 0.96M 0.75M 0.40M 0.52M
Common stock - 35.83M 35.83M 35.62M 33.61M
Capital stock 39.74M - 35.83M 35.62M 33.61M
Retained earnings -36.19032M -34.80438M -32.16767M -29.09735M -23.76524M
Other liab - - - - -
Good will - - - 0.00000M 0.83M
Other assets - - - 0.37M 0.36M
Cash 0.90M 0.11M 0.19M 1.10M 3.16M
Cash and equivalents - - - 1.10M 3.16M
Total current liabilities 0.57M 1.30M 1.01M 0.74M 0.95M
Current deferred revenue - - -0.52312M -0.09575M -0.23027M
Net debt - -0.03131M 0.32M -0.61003M -2.14553M
Short term debt - 0.07M 0.51M 0.10M 0.23M
Short long term debt 0.09M - 0.51M 0.05M 0.15M
Short long term debt total - 0.07M 0.51M 0.49M 1.01M
Other stockholder equity - - -4.98926M -8.80916M -12.00059M
Property plant equipment - - 0.01M 4.53M 5.22M
Total current assets 1.13M 2.52M 5.10M 2.72M 4.70M
Long term investments - - - 0.36M 0.70M
Net tangible assets - - 3.12M 6.84M 9.25M
Short term investments - - - 0.00000M -
Net receivables 0.04M 0.08M 0.12M 0.25M 0.35M
Long term debt - - 0.00000M 0.39M 0.41M
Inventory 0.18M 0.14M 0.60M 1.36M 1.19M
Accounts payable 0.26M 0.26M 0.26M 0.34M 0.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.19M 0.43M 0.42M 0.34M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00000M - -4.98786M 0.01M
Deferred long term asset charges - - - - -
Non current assets total 3.00M 0.00018M 0.01M 5.36M 7.22M
Capital lease obligations - - 0.00428M 0.05M 0.45M
Long term debt total - - 0.00000M 0.40M 0.78M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 2.13M 0.87M 0.50M -0.02605M -0.26338M
Change to liabilities - - -0.04588M -0.07386M 0.26M
Total cashflows from investing activities 2.13M 0.87M 0.50M -0.02605M -0.26338M
Net borrowings -0.62939M 0.15M 0.02M -0.26581M -0.10919M
Total cash from financing activities 0.28M 0.15M 0.24M 1.74M 0.53M
Change to operating activities - - - - -
Net income -1.57995M -1.54870M -4.04389M -5.37195M -3.63069M
Change in cash 0.80M -0.08632M -0.90994M -2.05799M -1.97800M
Begin period cash flow 0.11M 0.19M 1.10M 3.16M 5.14M
End period cash flow 0.90M 0.11M 0.19M 1.10M 3.16M
Total cash from operating activities -1.61554M -1.10696M -1.64909M -3.77178M -2.24404M
Issuance of capital stock 1.03M - 0.22M 2.14M 0.66M
Depreciation - 0.00704M 0.23M 0.33M 0.32M
Other cashflows from investing activities 2.13M 0.84M 0.50M - 0.00000M
Dividends paid - - 0.12M 0.11M -
Change to inventory -0.04244M 0.46M 0.61M -0.25394M -0.37318M
Change to account receivables 0.03M 0.04M 0.07M 0.10M 0.56M
Sale purchase of stock -0.12401M 0.00000M -0.00500M -0.13503M -0.01788M
Other cashflows from financing activities -0.12401M -0.00428M 0.19M 0.11M -0.09888M
Change to netincome - - 1.53M 1.50M 0.61M
Capital expenditures 0.00000M 0.00000M 0.00163M 0.03M 0.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.12747M 0.61M 0.68M -0.14898M 0.19M
Stock based compensation - - 0.02M 0.11M 0.19M
Other non cash items -1.48806M -0.17196M 2.16M 1.27M 1.06M
Free cash flow -1.61554M -1.10696M -1.65072M -3.79782M -2.50743M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EVE
EVE Health Group Limited		 - -% 0.02 - - 4.39 1.59 3.74 -1.0462
A2M
The a2 Milk Company Ltd		 0.10 1.05% 9.58 36.46 27.47 3.34 6.03 3.74 21.65
BGA
Bega Cheese Ltd		 0.06 1.04% 5.82 192.00 21.74 0.48 1.79 0.61 57.49
CBO
Cobram Estate Olives Ltd		 0.10 3.38% 3.06 29.60 - 6.05 2.77 6.91 14.78
RIC
Ridley Corporation Ltd		 0.10 3.75% 2.77 13.85 13.42 0.62 1.85 0.88 14.90

Reports Covered

Stock Research & News

View All

Profile

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

EVE Health Group Limited

245 Churchill Avenue, Subiaco, WA, Australia, 6008

Key Executives

Name Title Year Born
Mr. Gregory William Fry MD & CEO 1966
Mr. Benedict James Rohr Chief Operating Officer NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Sec. NA
Ms. Elizabeth Caiulo Admin. Professional NA
Ms. Beck Howe Sales & Marketing Professional NA
Ms. Stephanie Yip Marketing Director NA
Ms. Robyn Ingersole Chief Exec. Officer of Naturally Australian Products NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.